Mitchell Mcleod Pugh & Williams Inc Pfizer Inc Transaction History

Mitchell Mcleod Pugh & Williams Inc

$531 Million
Q2 2025

A detailed history of Mitchell Mcleod Pugh & Williams Inc transactions in Pfizer Inc stock. As of the latest transaction made, Mitchell Mcleod Pugh & Williams Inc holds 42,316 shares of PFE stock, worth $1.05 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

42,316

Previous 34,457 22.81%

Holding current value

$1.05 Million

Previous $873,000 17.41%

% of portfolio

0.19%

Previous 0.18%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 28, 2025	BUY	$21.59 - $24.84 $169,675 - $195,217	7,859 Added 22.81%	42,316 $1.03 Million
Q1 2025 May 01, 2025	BUY	$25.01 - $27.13 $33,288 - $36,110	1,331 Added 4.02%	34,457 $873,000
Q4 2024 Jan 16, 2025	BUY	$24.8 - $30.19 $8,035 - $9,781	324 Added 0.99%	33,126 $878,000
Q3 2024 Nov 04, 2024	BUY	$27.7 - $31.39 $4,487 - $5,085	162 Added 0.5%	32,802 $949,000
Q2 2024 Jul 31, 2024	BUY	$25.26 - $29.6 $909 - $1,065	36 Added 0.11%	32,640 $913,000
Q1 2024 May 01, 2024	SELL	$25.89 - $29.73 $17,009 - $19,532	-657 Reduced 1.98%	32,604 $904,000
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $46,955 - $60,990	-1,797 Reduced 5.13%	33,261 $957,000
Q3 2023 Oct 20, 2023	BUY	$32.09 - $37.51 $513 - $600	16 Added 0.05%	35,058 $1.16 Million
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $108 - $125	3 Added 0.01%	35,042 $1.29 Million
Q1 2023 May 10, 2023	BUY	$39.39 - $51.28 $3,269 - $4,256	83 Added 0.24%	35,039 $1.43 Million
Q4 2022 Feb 03, 2023	BUY	$41.75 - $54.5 $40,831 - $53,301	978 Added 2.88%	34,956 $1.79 Million
Q3 2022 Nov 07, 2022	BUY	$43.76 - $53.42 $9,714 - $11,859	222 Added 0.66%	33,978 $1.49 Million
Q2 2022 Nov 18, 2022	SELL	$46.53 - $55.17 $10,329 - $12,247	-222 Reduced 0.65%	33,756 $1.77 Million
Q2 2022 Jul 19, 2022	SELL	$46.53 - $55.17 $17,262 - $20,468	-371 Reduced 1.09%	33,756 $1.77 Million
Q1 2022 Apr 26, 2022	BUY	$45.75 - $56.69 $30,240 - $37,472	661 Added 1.98%	34,127 $1.77 Million
Q4 2021 Feb 02, 2022	BUY	$41.32 - $61.25 $20,660 - $30,625	500 Added 1.52%	33,466 $1.98 Million
Q2 2021 Nov 08, 2021	BUY	$35.91 - $40.68 $11,024 - $12,488	307 Added 0.94%	32,966 $1.29 Million
Q2 2021 Aug 03, 2021	BUY	$35.91 - $40.68 $17,955 - $20,340	500 Added 1.55%	32,659 $1.28 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $36,303 - $40,942	1,084 Added 3.49%	32,159 $1.17 Million
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $535 - $680	-16 Reduced 0.05%	31,075 $1.14 Million
Q3 2020 Oct 27, 2020	BUY	$31.75 - $37.25 $59,848 - $70,216	1,885 Added 6.45%	31,091 $1.14 Million
Q2 2020 Jul 17, 2020	BUY	$30.12 - $36.54 $361,530 - $438,589	12,003 Added 69.77%	29,206 $955,000
Q1 2020 Apr 08, 2020	SELL	$27.03 - $38.62 $113,282 - $161,856	-4,191 Reduced 19.59%	17,203 $562,000
Q4 2019 Jan 08, 2020	BUY	$32.92 - $37.36 $7,571 - $8,592	230 Added 1.09%	21,394 $838,000
Q3 2019 Oct 08, 2019	BUY	$32.49 - $42.13 $53,446 - $69,303	1,645 Added 8.43%	21,164 $760,000
Q2 2019 Jul 09, 2019	SELL	$36.98 - $41.52 $30,582 - $34,337	-827 Reduced 4.06%	19,519 $846,000
Q1 2019 Apr 11, 2019	BUY	$37.5 - $41.2 $46,200 - $50,758	1,232 Added 6.45%	20,346 $864,000
Q4 2018 Jan 10, 2019	BUY	$38.47 - $43.86 $4,231 - $4,824	110 Added 0.58%	19,114 $834,000
Q3 2018 Oct 09, 2018	SELL	$34.47 - $41.81 $448 - $543	-13 Reduced 0.07%	19,004 $838,000
Q2 2018 Jul 13, 2018	BUY	$32.98 - $35.16 $39,081 - $41,664	1,185 Added 6.65%	19,017 $690,000
Q1 2018 Apr 16, 2018	SELL	$31.91 - $37.02 $9,987 - $11,587	-313 Reduced 1.72%	17,832 $632,000
Q4 2017 Jan 12, 2018	BUY	$33.26 - $35.29 $10,410 - $11,045	313 Added 1.76%	18,145 $658,000
Q3 2017 Oct 12, 2017	BUY	$31.0 - $34.15 $552,792 - $608,962	17,832	17,832 $636,000

Others Institutions Holding PFE

# of Institutions

3,296

Shares Held

3.66B

Call Options Held

96M

Put Options Held

121M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $139B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Mcleod Pugh & Williams Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Mcleod Pugh & Williams Inc with notifications on news.

Account

Mitchell Mcleod Pugh & Williams Inc Pfizer Inc Transaction History